Australian Clinical LabsACL 
$2.390.85%24h
0.85%24h
Global rank11622
Market cap$483.38M
Change 7d10.97%
YTD Performance22.92%
SP500 benchmarkOutperform
P/E0
P/S1.03
Revenue$468.23M
Earnings$24.38M
Dividend yield-
Main Sector
Healthcare
Australian Clinical Labs ACL Total Debt
ACL Total Debt in 2022: $145.61M
According to Australian Clinical Labs latest financial reports the total debt is $145.61M, an increase of 28.41% to 2022. At the end of 2022 company had $113.39M total debt. This figure represents the debts and financial obligations that Australian Clinical Labs combine short-term debt, long-term debt, and other fixed payment obligations (such as capital leases) of a business that are incurred while under normal operating cycles.
Australian Clinical Labs ACL Total Debt History from 2023 to 2022
-
Value:-
ACL Total Debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023 | $145.61M | 28.41% |
| 2022 | $113.39M | -25.19% |
| 2021 | $151.58M | 12.48% |
| 2020 | $134.77M | - |
View the Top Total Debt Stocks 
